Bengaluru, Feb. 5 -- The shares of Chennai-based Pharmaceutical stock surged as much as 5.7% today after its subsidiary company received its final approval from the USFDA for its Procainamide Hydrochloride Injection.

Share Price Movement

The shares of Caplin Point Lab Ltd, with a market capitalization of Rs 16,722 Crores, closed at Rs 2,199 per share 4.4% higher than its previous close of Rs 2,107. The shares generated a return of 57% in 1 year, 172% in 3 years, and an impressive 703% in 5 years respectively.

What Happened

As per a press release dated February 5,2025, the U.S. Food and Drug Administration has granted its final approval to the subsidiary company of Caplin Point Lab Ltd called Caplin Steriles Ltd.

Caplin Steriles Ltd g...